ABSTRACT
INTRODUCTION: Periprosthetic joint infection (PJI) represents a devastating complication of total joint arthroplasty associated with significant morbidity and mortality. Literature suggests a possible higher incidence of periprosthetic joint infection (PJI) in patients with rheumatoid arthritis (RA). There is, however, no consensus on this purported risk nor a well-defined mechanism. This study investigates how collagen-induced arthritis (CIA), a validated animal model of RA, impacts infectious burden in a well-established model of PJI. METHODS: Control mice were compared against CIA mice. Whole blood samples were collected to quantify systemic IgG levels via ELISA. Ex vivo respiratory burst function was measured via dihydrorhodamine assay. Ex vivo Staphylococcus aureus Xen36 burden was measured directly via colony forming unit (CFU) counts and crystal violet assay to assess biofilm formation. In vivo, surgical placement of a titanium implant through the knee joint and inoculation with S. aureus Xen36 was performed. Bacterial burden was then quantified by longitudinal bioluminescent imaging. RESULTS: Mice with CIA demonstrated significantly higher levels of systemic IgG compared with control mice (p = 0.003). Ex vivo, there was no significant difference in respiratory burst function (p = 0.89) or S. aureus bacterial burden as measured by CFU counts (p = 0.91) and crystal violet assay (p = 0.96). In vivo, no significant difference in bacterial bioluminescence between groups was found at all postoperative time points. CFU counts of both the implant and the peri-implant tissue were not significantly different between groups (p = 0.82 and 0.80, respectively). CONCLUSION: This study demonstrated no significant difference in S. aureus infectious burden between mice with CIA and control mice. These results suggest that untreated, active RA may not represent a significant intrinsic risk factor for PJI, however further mechanistic translational and clinical studies are warranted.
Subject(s)
Arthritis, Experimental , Arthroplasty, Replacement, Knee , Bone-Implant Interface , Knee Joint , Knee Prosthesis/microbiology , Staphylococcal Infections , Staphylococcus aureus/metabolism , Animals , Arthritis, Experimental/metabolism , Arthritis, Experimental/microbiology , Arthritis, Experimental/pathology , Bacterial Load , Bone-Implant Interface/microbiology , Bone-Implant Interface/pathology , Knee Joint/metabolism , Knee Joint/microbiology , Knee Joint/pathology , Knee Joint/surgery , Male , Mice , Risk Factors , Staphylococcal Infections/metabolism , Staphylococcal Infections/microbiology , Staphylococcal Infections/pathologyABSTRACT
The present in vivo study analyses both the inflammatory tissue reactions and the bone healing capacity of a newly developed bone substitute material (BSM) based on xenogeneic bone substitute granules combined with hyaluronate (HY) as a water-binding molecule. The results of the hyaluronate containing bone substitute material (BSM) were compared to a control xenogeneic BSM of the same chemical composition and a sham operation group up to 16 weeks post implantationem. A major focus of the study was to analyze the residual hyaluronate and its effects on the material-dependent healing behavior and the inflammatory tissue responses. The study included 63 male Wistar rats using the calvaria implantation model for 2, 8, and 16 weeks post implantationem. Established and Good Laboratory Practice (GLP)-conforming histological, histopathological, and histomorphometrical analysis methods were conducted. The results showed that the new hyaluronate containing BSM was gradually integrated within newly formed bone up to the end of the study that ended in a condition of complete bone defect healing. Thereby, no differences to the healing capacity of the control BSM were found. However, the bone formation in both groups was continuously significantly higher compared to the sham operation group. Additionally, no differences in the (inflammatory) tissue response that was analyzed via qualitative and (semi-) quantitative methods were found. Interestingly, no differences were found between the numbers of pro- and anti-inflammatory macrophages between the three study groups over the entire course of the study. No signs of the HY as a water-binding part of the BSM were histologically detectable at any of the study time points, altogether the results of the present study show that HY allows for an optimal material-associated bone tissue healing comparable to the control xenogeneic BSM. The added HY seems to be degraded within a very short time period of less than 2 weeks so that the remaining BSM granules allow for a gradual osteoconductive bone regeneration. Additionally, no differences between the inflammatory tissue reactions in both material groups and the sham operation group were found. Thus, the new hyaluronate containing xenogeneic BSM and also the control BSM have been shown to be fully biocompatible without any differences regarding bone regeneration.
Subject(s)
Bone Substitutes/pharmacology , Bone Transplantation , Osteogenesis/drug effects , Skull/growth & development , Animals , Bone Regeneration/drug effects , Bone Substitutes/chemistry , Bone-Implant Interface/growth & development , Bone-Implant Interface/pathology , Humans , Hyaluronic Acid/pharmacology , Hydroxyapatites/pharmacology , Materials Testing , Rats , Rats, Wistar , Skull/drug effects , Water/chemistry , Wound Healing/drug effectsABSTRACT
The objective of this study was to find out if suppression of NF-kB complex function by p65-TMD-linked PTD could reduce host inflammation and bone resorption at peri-implantitis sites in rats. Twenty-one male 5-week-old SD rats were divided into three groups: untreated control group (A), silk-induced peri-implantitis group (B), and nt (nucleus transducible)-p65-TMD-treated, silk-induced peri-implantitis group (C). Implant sulcus of a rat in group C were divided into two groups, namely group Cp and Cb. Palatal implant sulcus where nt-p65-TMD solution was applied with an insulin syringe were assigned to group Cp. Buccal implant sulcus without topical nt-p65-TMD application were assigned to group Cb. H&E staining, TRAP staining, and immunohistological staining were done. The crestal bone levels of group A were significantly higher than those of group B at p<0.01. The crestal bone levels of group Cp were significantly higher than those of group Cb at p<0.05. H-E staining showed increased apical migration of junctional epithelium and inflammatory cells in group Cb. TRAP staining revealed more multinucleated osteoclasts in group Cb. As for immunohistological staining, group Cb showed many IL-6-positive cells while group Cp had none. In this study, p65-TMD-linked PTD inhibited NF-kB functions and reduced inflammation and bone resorption at peri-implantitis sites in rats.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Bone Resorption/prevention & control , Inflammation Mediators/antagonists & inhibitors , Inflammation/prevention & control , Jaw/drug effects , NF-kappa B/antagonists & inhibitors , Peri-Implantitis/prevention & control , Animals , Bone Resorption/immunology , Bone Resorption/metabolism , Bone Resorption/pathology , Bone Screws , Bone-Implant Interface/pathology , Disease Models, Animal , Inflammation/immunology , Inflammation/metabolism , Inflammation/pathology , Inflammation Mediators/metabolism , Interleukin-6/metabolism , Jaw/immunology , Jaw/metabolism , Jaw/pathology , Male , NF-kappa B/metabolism , Osteoclasts/drug effects , Osteoclasts/immunology , Osteoclasts/metabolism , Osteoclasts/pathology , Peri-Implantitis/immunology , Peri-Implantitis/metabolism , Peri-Implantitis/pathology , Rats, Sprague-DawleyABSTRACT
INTRODUCTION: Implant material is a more important factor for periprosthetic tibial bone resorption than implant design after total knee arthroplasty (TKA). The virtual perturbation study was planned to perform using single case of proximal tibia model. We determined whether the implant materials' stiffness affects the degree of periprosthetic tibial bone resorption, and whether the effect of material change with the same implant design differed according to the proximal tibial plateau areas. MATERIALS AND METHODS: This three-dimensional finite element analysis included two cobalt-chromium (CoCr) and two titanium (Ti) tibial implants with different designs. They were implanted into the proximal tibial model reconstructed using extracted images from computed tomography. The degree of bone resorption or formation was measured using the strain energy density after applying axial load. The same analysis was performed after exchanging the materials while maintaining the design of each implant. RESULTS: The degree of periprosthetic tibial bone resorption was not determined by the type of implant materials alone. When the implant materials were changed from Ti to CoCr, the bone resorption in the medial compartment increased and vice versa. The effect of material composition's change on anterior and posterior areas varied accordingly. CONCLUSIONS: Although the degree of bone resorption was associated with implant materials, it differed depending on the design of each implant. The effect on the degree of bone resorption according to the materials after TKA should be evaluated while concomitantly considering design.
Subject(s)
Bone Resorption , Bone-Implant Interface/pathology , Prostheses and Implants , Prosthesis Design , Tibia , Bone Resorption/metabolism , Bone Resorption/pathology , Bone Resorption/prevention & control , Chromium Alloys/pharmacology , Finite Element Analysis , Humans , Tibia/metabolism , Tibia/physiology , Titanium/pharmacologyABSTRACT
This study compares the longitudinal histological characteristics of proximal humeral implants with different spatial structures in rabbits. Thirty skeletally-mature male rabbits were divided into a trabecular structure group and regular hexahedron structure group according to the different spatial structures of a biological titanium alloy screw inserted into the greater tuberosity of the proximal humerus. Samples were collected 3, 6, and 12 weeks after the implantation surgery. Histological results showed that the amount of bone in-growth in the porous cavity of the screw implant increased over time. Quantitative analysis showed there was significantly more bone in-growth in the trabecular structure group than the classic structure group 3 weeks (25.4% ± 6.9% vs 19.6% ± 3.7%, P < 0.05) and 6 weeks (31.2% ± 1.7% vs 26.9% ± 5.3, P < 0.05) after the implantation surgery. No significant difference was detected between the two groups 12 weeks after the surgery (41.7% ± 2.5% vs 39% ± 4.1%, P > 0.05). Our data found that bone in-growth significantly differed among the three time points (P < 0.05) in both groups, but not between the implants with different spatial structures 12 weeks after the surgery.
Subject(s)
Bone-Implant Interface/pathology , Humerus/pathology , Prosthesis Design , Animals , Arthroplasty, Replacement, Shoulder , Bone Screws , Humerus/surgery , Osseointegration , Porosity , Rabbits , TitaniumABSTRACT
BACKGROUND: Dental implants have become well-established in oral rehabilitation for fully or partially edentulous patients. However, peri-implantitis often leads to the failure of dental implants. The aim of this study was to understand the core microbiome associated with peri-implantitis and evaluate potential peri-implantitis pathogens based on canine peri-implantitis model. RESULTS: In this study, three beagle dogs were used to build peri-implantitis models with ligature-induced strategy. The peri-implant sulcular fluids were collected at four different phases based on disease severity during the peri-implantitis development. Microbial compositions during peri-implantitis development were monitored and evaluated. The microbes were presented with operational taxonomic unit (OTU) classified at 97% identity of the high-throughput 16S rRNA gene fragments. Microbial diversity and richness varied during peri-implantitis. At the phylum-level, Firmicutes decreased and Bacteroides increased during peri-implantitis development. At the genus-level, Peptostreptococcus decreased and Porphyromonas increased, suggesting peri-implantitis pathogens might be assigned to these two genera. Further species-level and co-occurrence network analyses identified several potential keystone species during peri-implantitis development, and some OTUs were potential peri-implantitis pathogens. CONCLUSION: In summary, canine peri-implantitis models help to identify several potential keystone peri-implantitis associated species. The canine model can give insight into human peri-implantitis associated microbiota.
Subject(s)
Bone-Implant Interface/microbiology , Dental Implants/microbiology , Microbiota/genetics , Peri-Implantitis/microbiology , Animals , Bacterial Typing Techniques , Bacteroides/classification , Bacteroides/genetics , Bacteroides/isolation & purification , Bone-Implant Interface/pathology , Disease Models, Animal , Dogs , Firmicutes/classification , Firmicutes/genetics , Firmicutes/isolation & purification , Genetic Variation , Humans , Ligation/adverse effects , Male , Peptostreptococcus/classification , Peptostreptococcus/genetics , Peptostreptococcus/isolation & purification , Peri-Implantitis/etiology , Peri-Implantitis/pathology , Phylogeny , Porphyromonas/classification , Porphyromonas/genetics , Porphyromonas/isolation & purification , RNA, Ribosomal, 16S/genetics , Spirochaeta/classification , Spirochaeta/genetics , Spirochaeta/isolation & purificationABSTRACT
Donepezil is an acetylcholinesterase inhibitor commonly used to treat mild to moderate Alzheimer's disease. Its use has been associated with increased bone mass in humans and animals. However, the effect of postoperative administration of donepezil on bone healing remains unknown. Therefore, this study aimed to assess the impact of postoperative injection of donepezil on bone healing, titanium-implant osseointegration, and soft tissue healing. Twenty-two Sprague-Dawley rats were randomly assigned to receive a daily dose of either donepezil (0.6 mg/kg) or saline as a control. In each rat, a uni-cortical defect was created in the right tibia metaphysis and a custom-made titanium implant was placed in the left tibiae. After two weeks, rats were euthanized, and their bones were analysed by Micro-CT and histology. The healing of bone defect and implant osseointegration in the rats treated with donepezil were significantly reduced compared to the saline-treated rats. Histomorphometric analysis showed lower immune cell infiltration in bone defects treated with donepezil compared to the saline-treated defects. On the other hand, the healing time of soft tissue wounds was significantly shorter in donepezil-treated rats compared to the controls. In conclusion, short-term administration of donepezil hinders bone healing whereas enhancing soft tissue healing.
Subject(s)
Bone-Implant Interface/pathology , Cholinesterase Inhibitors/adverse effects , Donepezil/adverse effects , Osseointegration/drug effects , Tibial Fractures/pathology , Wound Healing/drug effects , Animals , Bone Substitutes/chemistry , Bone-Implant Interface/diagnostic imaging , Female , Rats , Rats, Sprague-Dawley , Tibia/diagnostic imaging , Tibia/drug effects , Tibia/injuries , Tibial Fractures/diagnostic imaging , Titanium/chemistry , X-Ray MicrotomographyABSTRACT
Natural or synthetic biomaterials are increasingly being used to support bone tissue repair or substitution. The combination of natural calcium phosphates with biocompatible alloys is an important route towards the development of new biomaterials with bioperformance and mechanical responses to mimic those of human bones. This article evaluated the structural, physical, mechanical and biological properties of a new mechanical improved nanocomposite elaborated by association of fish biphasic calcium phosphate (BCP) and niobium pentoxide (Nb2O5). The nanocomposite (Nb-BCP) and the pure BCP, used as a positive control, were obtained by powder metallurgy. The density, porosity and microhardness were measured. The structural analysis was determined by X-ray diffraction (XRD) and the biological properties were studied in histological sections of critical size calvaria defects in rats, 7, 15, 30, 45 and 60 days after implantation of disks of both materials. Morphological description was made after scanning electron microscopy (SEM) and optical microscopy analysis. After sintering, the Nb-BCP nanocomposite presented four crystalline phases: 34.36% calcium niobate (CaNb2O6), 21.68% phosphorus niobium oxide (PNb9O25), 42.55% ß-tricalcium phosphate (Ca3(PO4)2) and 1.31% of niobium pentoxide (Nb2O5) and exhibited increases of 17% in density, 66% in Vickers microhardness and 180% in compressive strength compared to pure BCP. In vivo study, showed biocompatibility, bioactivity and osteoconductivity similar to pure BCP. SEM showed the formation of globular accretions over the implanted nanocomposites, representing one of the stages of bone mineralization. In conclusion, the BCP and Nb2O5 formed a nanocomposite exhibiting characteristics that are desirable for a biomaterial, such as bioperformance, higher ß-TCP percentage and improved physical and mechanical properties compared to pure BCP. These characteristics demonstrate the promise of this material for supporting bone regeneration.
Subject(s)
Bone Substitutes/chemistry , Calcium Phosphates/chemistry , Niobium/chemistry , Osseointegration , Oxides/chemistry , Skull Fractures/therapy , Animals , Bone Regeneration/drug effects , Bone Substitutes/pharmacology , Bone Substitutes/therapeutic use , Bone-Anchored Prosthesis , Bone-Implant Interface/pathology , Calcium Phosphates/chemical synthesis , Calcium Phosphates/therapeutic use , Disease Models, Animal , Hydroxyapatites/chemical synthesis , Hydroxyapatites/chemistry , Hydroxyapatites/therapeutic use , Male , Materials Testing , Microscopy, Electron, Scanning , Nanocomposites/chemistry , Nanocomposites/therapeutic use , Niobium/therapeutic use , Osseointegration/drug effects , Oxides/chemical synthesis , Oxides/therapeutic use , Rats , Rats, Wistar , Skull Fractures/pathology , X-Ray DiffractionABSTRACT
This study investigated the effect of three different parameters of a dental implant on stress and strain values in the peri-implant bone by finite element analysis. In this work, the effect of diameter, length and elastic modulus on the biomechanical behavior of a new dental implant was simulated using the finite element method. A three-dimensional model of a mandible segment corresponding to the premolar region and twelve dental implant models were obtained. Loads in three directions were distributed on the surface of the coronal area of the dental implants. The dental implant models were obtained in the FreeCAD 0.16 software and the simulations were made using the Abaqus/CAE software. In all cases, higher stress concentrations were obtained in the peri-implant cortical bone between 40.6 and 62.8 MPa, while the highest levels of strain were observed in the peri-implant trabecular bone between 0.002544 and 0.003873. In general, the highest von Mises equivalent stress values were observed in the peri-implant cortical bone. However, in this bone, both the maximum von Mises equivalent stress values and the von Mises strain are similar or inferior to those reported in different studies by finite element for other models of dental implants under immediate loading. Maximum von Mises strain values were observed in peri-implant trabecular bone. However, in this bone strains levels were obtained that maintain bone density or increase it. The effect of the three simulated variables (implant diameter, length, and elastic modulus) have a statistically significant influence on the von Mises equivalent stress and in von Mises strain values.
Subject(s)
Bone-Implant Interface , Dental Implants , Dental Prosthesis Design , Dental Stress Analysis/methods , Finite Element Analysis , Biomechanical Phenomena/physiology , Bone-Implant Interface/pathology , Bone-Implant Interface/physiopathology , Dental Implants/standards , Elastic Modulus , Humans , Imaging, Three-Dimensional , Mandible/pathology , Mandible/physiology , Models, Dental , Stress, Mechanical , Weight-Bearing/physiologyABSTRACT
Soft tissue defects around dental implants, such as papilla or volume loss, peri-implant recession and alterations of the ridge color and/or texture, lead to esthetic and functional complaints. Treatments of these defects in implants are more demanding than in teeth because peri-implant tissue exhibits different anatomical and histological characteristics. This narrative review discusses the proposed treatments for soft tissue defects around implants in the current literature. Several clinical and pre-clinical studies addressed methods to augment the quantity of the peri-implant keratinized mucosa. Autogenous grafts performed better than soft tissue substitutes in the treatment of soft tissue defects, but there is no clinical consensus on the more appropriate donor area for connective tissue grafts. Treatment for facial volume loss, alterations on the mucosa color or texture and shallow peri-implant recessions are more predictable than deep recessions and sites that present loss of papilla. Correction of peri-implant soft tissue defects may be challenging, especially in areas that exhibit larger defects and interproximal loss. Therefore, the regeneration of soft and hard tissues during implant treatment is important to prevent the occurrence of these alterations.
Subject(s)
Alveolar Bone Loss/therapy , Bone-Anchored Prosthesis/adverse effects , Bone-Implant Interface , Dental Implants/adverse effects , Gingival Recession/therapy , Alveolar Bone Loss/etiology , Alveolar Bone Loss/pathology , Bone-Implant Interface/pathology , Face/pathology , Gingival Recession/etiology , Gingival Recession/pathology , Humans , Reproducibility of Results , Treatment OutcomeABSTRACT
AIMS: It is increasingly appreciated that coordinated regulation of angiogenesis and osteogenesis is needed for bone formation. How this regulation is achieved during peri-implant bone healing, such as osseointegration, is largely unclear. This study examined the relationship between angiogenesis and osteogenesis in a unique model of osseointegration of a mouse tibial implant by pharmacologically blocking the vascular endothelial growth factor (VEGF) pathway. MATERIALS AND METHODS: An implant was inserted into the right tibia of 16-week-old female C57BL/6 mice (n = 38). Mice received anti-VEGF receptor-1 (VEGFR-1) antibody (25 mg/kg) and VEGF receptor-2 (VEGFR-2) antibody (25 mg/kg; n = 19) or an isotype control antibody (n = 19). Flow cytometric (n = 4/group) and immunofluorescent (n = 3/group) analyses were performed at two weeks post-implantation to detect the distribution and density of CD31hiEMCNhi endothelium. RNA sequencing analysis was performed using sorted CD31hiEMCNhi endothelial cells (n = 2/group). Osteoblast lineage cells expressing osterix (OSX) and osteopontin (OPN) were also detected with immunofluorescence. Mechanical pull-out testing (n = 12/group) was used at four weeks post-implantation to determine the strength of the bone-implant interface. After pull-out testing, the tissue attached to the implant surface was harvested. Whole mount immunofluorescent staining of OSX and OPN was performed to determine the amount of osteoblast lineage cells. RESULTS: Flow cytometry revealed that anti-VEGFR treatment decreased CD31hiEMCNhi vascular endothelium in the peri-implant bone versus controls at two weeks post-implantation. This was confirmed by the decrease of CD31 and endomucin (EMCN) double-positive cells detected with immunofluorescence. In addition, treated mice had more OPN-positive cells in both peri-implant bone and tissue on the implant surface at two weeks and four weeks, respectively. More OSX-positive cells were present in peri-implant bone at two weeks. More importantly, anti-VEGFR treatment decreased the maximum load of pull-out testing compared with the control. CONCLUSION: VEGF pathway controls the coupling of angiogenesis and osteogenesis in orthopaedic implant osseointegration by affecting the formation of CD31hiEMCNhi endothelium. Cite this article: Bone Joint J 2019;101-B(7 Supple C):108-114.
Subject(s)
Angiogenesis Inhibitors/pharmacology , Bone-Implant Interface/pathology , Osseointegration/drug effects , Prostheses and Implants , Tibia/surgery , Titanium , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Animals , Disease Models, Animal , Female , Mice , Mice, Inbred C57BL , Tibia/drug effects , Tibia/metabolism , Tibia/pathologyABSTRACT
Purpose: On the basis of reasonable superposition of various surface treatment methods, alkali-treated titanium with nanonetwork structures (TNS) was coated with mussel adhesive protein (MAP) and named TNS-MAP. The aims were to optimize the biological properties of TNS, endue it with new properties, and enhance its utility in clinical dental applications. Methods: TNS disks were coated with MAP and the product surface was characterized. Its osteogenic properties were determined by evaluating its effects on cell adhesion, cell proliferation, the expression of osteogenesis-related genes, and in vivo experiments. Results: The treated materials showed excellent hydrophilicity, good surface roughness, and advantages of both TNS and MAP. TNS-MAP significantly promoted initial cell attachment especially after 15 mins and 30 mins. At every time point, cell adhesion and proliferation, the detection rate of osteogenesis-related markers in the extracellular matrix, and the expression of osteogenesis-related genes were markedly superior on TNS-MAP than the control. The in vivo experiments revealed that TNS-MAP promoted new bone growth around the implants and the bone-implant interface. Conclusion: We verified through in vitro and in vivo experiments that we successfully created an effective TNS-MAP composite implant with excellent biocompatibility and advantages of both its TNS and MAP parent materials. Therefore, the new biocomposite implant material TNS-MAP may potentially serve in practical dentistry and orthopedics.
Subject(s)
Alkalies/chemistry , Coated Materials, Biocompatible/pharmacology , Nanoparticles/chemistry , Osseointegration/drug effects , Osteogenesis/drug effects , Proteins/pharmacology , Titanium/pharmacology , Alkaline Phosphatase/metabolism , Animals , Bone-Implant Interface/diagnostic imaging , Bone-Implant Interface/pathology , Cell Adhesion/drug effects , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cell Shape/drug effects , Humans , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/drug effects , Rats, Sprague-Dawley , Spectroscopy, Fourier Transform Infrared , X-Ray MicrotomographyABSTRACT
Trabecular resorption from interdigitated regions between cement and bone has been found in postmortem-retrieved knee replacements, but the viability of interdigitated bone, and the mechanism responsible for this bone loss is not known. In this work, a Sprague-Dawley (age 12 weeks) rat knee replacement model with an interdigitated cement-bone interface was developed. Morphological and cellular changes in the interdigitated region of the knee replacement over time (0, 2, 6, or 12 weeks) were determined for ovariectomy (OVX) and Sham OVX treatment groups. Interdigitated bone volume fraction (BV/TV) increased with time for Sham OVX (0.022 BV/TV/wk) and OVX (0.015 BV/TV/wk) group, but the rate of increase was greater for the Sham OVX group (p = 0.0064). Tissue mineral density followed a similar increase with time in the interdigitated regions. Trabecular resorption, when it did occur, started at the cement border with medullary-adjacent bone in the presence of osteoclasts. There was substantial loss of viable bone (~80% empty osteocyte lacunae) in the interdigitated regions. Pre-surgical fluorochrome labels remained in the interdigitated regions, and did not diminish with time, indicating that the bone was not remodeling. There was also some evidence of continued surface mineralization in the interdigitated region after cementing of the knee, but this diminished over time. Statement of clinical significance: Interdigitated bone with cement provides mechanical stability for success of knee replacements. Improved understanding of the fate of the interdigitated bone over time could lead to a better understanding of the loosening process and interventions to prevent loss of fixation. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:2163-2171, 2019.
Subject(s)
Arthroplasty, Replacement, Knee , Bone-Implant Interface/pathology , Osteoporosis, Postmenopausal , Animals , Bone Cements , Calcification, Physiologic , Female , Humans , Osteoclasts , Rats, Sprague-DawleyABSTRACT
Negative Pressure Wound Therapy (NPWT) has been shown to limit downgrowth around percutaneous devices in a guinea pig model. However, the influence of NPWT on peri-prosthetic tissue characteristics leading to limited downgrowth is still unclear. In order to investigate this, 12 CD hairless rats were assigned into two groups, NPWT and Untreated (n = 6/group). Each animal was implanted with a porous coated titanium percutaneous device and was dressed with a gauze and semi-occlusive base dressing. Post-surgery, animals in the NPWT Group received a regimen of NPWT treatment (-70 to -90 mmHg). After 4 weeks, tissue was collected over the device and stained with CD31 and CD68 to quantify blood vessel density and inflammation, respectively. The device with the surrounding tissue was also collected to quantify downgrowth. NPWT treatment led to a 1.6-fold increase in blood vessel densities compared to untreated tissues (p < 0.05). NPWT treatment also resulted in half the downgrowth as the Untreated Group, although not statistically significant (p = 0.19). Additionally, the results showed a trend toward increased CD68 cell densities in the NPWT Group compared to the Untreated Group (p = 0.09). These findings suggest that NPWT may influence wound healing responses in percutaneous devices by increasing blood vessel densities, limiting downgrowth and potentially increasing inflammation. Overall, NPWT may enhance tissue vascularity around percutaneous devices, especially in patients with impaired wound healing. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 2091-2101, 2019.
Subject(s)
Bone-Implant Interface , Implants, Experimental/adverse effects , Negative-Pressure Wound Therapy , Neovascularization, Physiologic , Titanium , Wound Healing , Animals , Bone-Implant Interface/blood supply , Bone-Implant Interface/pathology , Female , Inflammation/metabolism , Inflammation/pathology , Mice , Mice, Hairless , Porosity , Titanium/adverse effects , Titanium/chemistry , Titanium/pharmacologyABSTRACT
OBJECTIVE: The aim of this study is to investigate the effects of recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone-implant osteointegration in osteoporotic rats. MATERIALS AND METHODS: Thirty-six female Wistar rats were randomly divided into 3 groups: sham-operation (SHAM), ovariectomized (OVX), and ovariectomized with rhBMP-2 (OVX + rhBMP-2). The bone density of right tibia was observed with x-ray and the serum alkaline phosphatase (ALP) activity was measured preovariectomy and postovariectomy using an ALP-kit. In OVX + rhBMP-2 group, rhBMP-2 was embedded in the peri-implant area, while SHAM and OVX groups did not contain rhBMP-2. Four and eight weeks after implantation, the rats were killed and the right tibia with implants was taken by x-ray. Histologic changes were investigated by hematoxylin and eosin staining, scanning electron microscope (SEM), and energy dispersive spectrometer examinations. RESULTS: The serum ALP level was significantly higher in ovariectomized rats compared with that before ovariectomy (Pâ<â0.05), while no difference was found in SHAM rats. At 12 weeks after ovariectomy, radiographic and histologic findings showed significant osteoporotic changes in proximal tibial metaphyses of OVX rats, including reduced cortical bone density and enlargement of bone marrow cavity compared with SHAM ones. The results of implantation verified new bone formation around implants in OVX + rhBMP-2 and SHAM groups, indicating favorable bone healing and osseointegration. No bone resorption was found in OVX + rhBMP-2 group, while some soft tissue was observed in bone-implant interface in SHAM group. In OVX group, there was no effective bone-implant osseointegration and mature bone formed around implants, and some implants were even lost due to chronic inflammation. The percentage of calcium and phosphorous atoms was significantly higher and the percentage of sulfur element was significantly lower in peri-implant area in OVX + rhBMP-2 and SHAM groups than that in OVX group. CONCLUSION: rhBMP-2 could enhance the osseous healing and restore bone-implant osseointegration in osteoporotic rats.
Subject(s)
Bone Morphogenetic Protein 2/therapeutic use , Bone-Implant Interface/pathology , Osseointegration/drug effects , Osteoporosis/complications , Ovariectomy , Tibia/surgery , Transforming Growth Factor beta/therapeutic use , Animals , Bone Density/physiology , Bone Density Conservation Agents , Bone-Anchored Prosthesis , Disease Models, Animal , Female , Osteoporosis/pathology , Rats , Rats, Wistar , Recombinant Proteins/therapeutic use , Tibia/pathology , Titanium/pharmacologyABSTRACT
The aim of the present study was a histologic and histomorphometric analysis of the peri-implant tissue reactions and of the bone-titanium interface in successfully osseointegrated, clinically stable, and immobile retrieved titanium dental implants after a long loading period. Four successfully osseointegrated and stable implants with a sandblasted surface were retrieved from a patient due to fracture, two after 14 years of loading and two after 17 years. None of these implants has been previously reported. Mature, compact bone with a few marrow spaces was observed around all four implants. At low magnification, a high percentage of bone-implant contact (BIC) was present at the interface of almost all implants. BIC percentage for the four implants was 83%, 66%, 74%, and 65%. In almost all the implants, the space within the threads was almost completely filled by compact bone. Close, tight contact between bone and implant surface was observed in all specimens, and no gaps or fibrous connective tissue was found at the bone-implant interface. All implants appeared to be well integrated in the surrounding mineralized bone, and all showed adequate BIC percentages after a long loading history.
Subject(s)
Bone-Implant Interface/anatomy & histology , Bone-Implant Interface/pathology , Dental Implantation, Endosseous , Dental Implants , Osseointegration , Adult , Bone and Bones/anatomy & histology , Bone and Bones/diagnostic imaging , Bone and Bones/pathology , Bone-Implant Interface/diagnostic imaging , Humans , Male , Surface Properties , Time Factors , TitaniumABSTRACT
Different zirconia porous layers were produced on zirconia dense zirconia substrates by slip casting using powder with different mean sizes: 40 µm (Z40), 70 µm (Z70), and 100 µm (Z100). The dynamic and static coefficients of friction against bovine femoral bone, mimicking the implantation process, were conducted using a ball-on-flat reciprocating sliding tribometer under 3 N of normal load. Additionally, the porous layers were assessed with regard to their low temperature degradation (aging). Results revealed that the porous layers were able to keep their integrity during the sliding testes against bone, with no zirconia particles being transferred to the bone. Results did not show significant differences (p > 0.05) in kinetic and static COF values for Z40, Z70, Z100, and GRAD specimens, ranging from 0.53 to 0.77 and 0.65 to 0.90, respectively. The aging tests revealed that all surfaces were prone to low temperature degradation (~49% of monoclinic content after 18 h). In conclusion, the cohesive integrity of the layers and relatively high COF observed reveled that zirconia porous layers may be considered for replacing the current implant surfaces, and are expected to improve their primary stability. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1113-1121, 2019.
Subject(s)
Bone-Implant Interface/pathology , Femur , Implants, Experimental , Zirconium , Animals , Cattle , Femur/chemistry , Femur/metabolism , Femur/pathology , PorosityABSTRACT
Periprosthetic infection via skin-implant interface is a leading cause of failures and revisions in direct skeletal attachment of limb prostheses. Implants with deep porosity fabricated with skin and bone integrated pylons (SBIP) technology allow for skin ingrowth through the implant's structure creating natural barrier against infection. However, until the skin cells remodel in all pores of the implant, additional care is required to prevent from entering bacteria to the still nonoccupied pores. Temporary silver coating was evaluated in this work as a means to provide protection from infection immediately after implantation followed by dissolution of silver layer in few weeks. A sputtering coating with 1 µm thickness was selected to be sufficient for fighting infection until the deep ingrowth of skin in the porous structure of the pylon is completed. In vitro study showed less bacterial (Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa) growth on silver coated tablets compared to the control group. Analysis of cellular density of MG-63 cells, fibroblasts, and mesenchymal stem cells (MSCs) showed that silver coating did not inhibit the cell growth on the implants and did not affect cellular functional activity. The in vivo study did not show any postoperative complications during the 6-month observation period in the model of above-knee amputation in rabbits when SBIP implants, either silver-coated or untreated were inserted into the bone residuum. Three-phase scintigraphy demonstrated angiogenesis in the pores of the pylons. The findings suggest that a silver coating with well-chosen specifications can increase the safety of porous implants for direct skeletal attachment. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 107B: 169-177, 2019.
Subject(s)
Anti-Bacterial Agents/chemistry , Bacteria/growth & development , Bacterial Infections , Bone-Implant Interface , Coated Materials, Biocompatible/chemistry , Implants, Experimental/microbiology , Silver/chemistry , Skin , Animals , Bacterial Infections/metabolism , Bacterial Infections/pathology , Bone-Implant Interface/microbiology , Bone-Implant Interface/pathology , Cell Line, Tumor , Humans , Male , Porosity , Rabbits , Skin/microbiology , Skin/pathologyABSTRACT
Abstract Soft tissue defects around dental implants, such as papilla or volume loss, peri-implant recession and alterations of the ridge color and/or texture, lead to esthetic and functional complaints. Treatments of these defects in implants are more demanding than in teeth because peri-implant tissue exhibits different anatomical and histological characteristics. This narrative review discusses the proposed treatments for soft tissue defects around implants in the current literature. Several clinical and pre-clinical studies addressed methods to augment the quantity of the peri-implant keratinized mucosa. Autogenous grafts performed better than soft tissue substitutes in the treatment of soft tissue defects, but there is no clinical consensus on the more appropriate donor area for connective tissue grafts. Treatment for facial volume loss, alterations on the mucosa color or texture and shallow peri-implant recessions are more predictable than deep recessions and sites that present loss of papilla. Correction of peri-implant soft tissue defects may be challenging, especially in areas that exhibit larger defects and interproximal loss. Therefore, the regeneration of soft and hard tissues during implant treatment is important to prevent the occurrence of these alterations.
Subject(s)
Humans , Dental Implants/adverse effects , Alveolar Bone Loss/therapy , Bone-Implant Interface/pathology , Bone-Anchored Prosthesis/adverse effects , Gingival Recession/therapy , Reproducibility of Results , Alveolar Bone Loss/etiology , Alveolar Bone Loss/pathology , Treatment Outcome , Face/pathology , Gingival Recession/etiology , Gingival Recession/pathologyABSTRACT
Modification of implants by antimicrobial peptides (AMPs) can improve the antimicrobial activity of the implants. However, AMPs have some cytotoxicity in vivo when they are exposed at body temperature. To tackle this challenge, we propose to develop a new approach to generating a smart antimicrobial surface through exposure of AMPs on the surface. A polydopamine film was first formed on the substrates, followed by the conjugation of a temperature-sensitive polymer, poly( N-isopropylacrylamide) (pNIPAM), to the film through atom transfer radical polymerization (ATRP). Then, AMPs were conjugated to the NIPAM on the resultant pNIPAM-modified surface through a click chemistry reaction. Because of the temperature-sensitive property of pNIPAM, the AMPs motif was more exposed to the external environment at room temperature (25 °C) than at body temperature (37 °C), making the surface present a higher antimicrobial activity at room temperature than at body temperature. More importantly, such a smart behavior is accompanied with the increased biocompatibility of the surface at body temperature when compared to the substrates unmodified or modified by AMPs or pNIPAM alone. Our in vivo study further verified that pNIPAM-AMP dual modified bone implants showed increased biocompatibility even when they were challenged with the bacteria at room temperature before implantation. These results indicate that the implants are antibacterial at room temperature and can be safely employed during surgery, resulting in no infection after implantations. Our work represents a new promising strategy to fully explore the antimicrobial property of AMPs, while improving their biocompatibility in vivo. The higher exposure of AMPs at room temperature (the temperature for storing the implants before surgery) will help decrease the risk of bacterial infection, and the lower exposure of AMPs at body temperature (the temperature after the implants are placed into the body by surgery) will improve the biocompatibility of AMPs.